Eyewire News

Featured Story

07.14.2026

Lexitas, Ocusun Enroll First Patient in Pilot Study of Investigational Cataract Eye Drop

Lexitas Pharma Services and Chinese partner Ocusun have enrolled the first patient in a multicenter pilot study evaluating ZOC2017217, an investigational topical therapy for cataracts that could offer a non-surgical treatment approach if successful. The randomized, double-masked, placebo-controlled study is designed to assess the efficacy and safety of ZOC2017217 in patients with age-related cataract and will help inform the design of an upcoming pivotal phase 3 program.

Read Story

Latest News Stories

University of Waterloo Researchers Develop 3D Printing Platform for Patient-Specific Contact Lenses image

07.14.2026

University of Waterloo Researchers Develop 3D Printing Platform for Patient-Specific Contact Lenses

07.14.2026

AMA Launches Interoperability Initiative to Advance Electronic Prior Authorization

07.14.2026

Dompé Enrolls First Patient in Global Phase 3 Trial of Intranasal NGF Therapy for NAION

07.13.2026

Nicotinamide Supplementation Associated With Reduced Risk of Glaucoma in Patients With Ocular Hypertension

07.13.2026

Tenpoint Therapeutics Submits Marketing Authorization Application in the UK for Yuvezzi, Its Dual-Agent Presbyopia Eye Drop

07.13.2026

FDA to Hold Advisory Committee to Review NDA for Low-Dose Atropine Therapy for Pediatric Progressive Myopia

Opus Genetics Provides BEST1 Program Update image

07.10.2026

Opus Genetics Provides BEST1 Program Update

Glaucoma Neuroprotective Candidate Does Not Meet Primary Endpoint image

07.10.2026

Glaucoma Neuroprotective Candidate Does Not Meet Primary Endpoint

07.10.2026

Low-Dose Atropine Slows Myopia Progression in UK Children, CHAMP-UK Trial Finds

Belgium-based Azalea Vision Secures Up to €7.5 Million Through to Advance Smart Contact Lens Platform image

07.10.2026

Belgium-based Azalea Vision Secures Up to €7.5 Million Through to Advance Smart Contact Lens Platform

Bausch + Lomb Introduces Orphia AI Platform for Cataract Patient Education image

07.09.2026

Bausch + Lomb Introduces Orphia AI Platform for Cataract Patient Education

Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema image

07.09.2026

Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema

07.09.2026

Teva, Samsung Bioepis Sign Canadian Commercialization Agreement for Aflibercept Biosimilar

07.09.2026

Atsena Selects Lead Clinical Candidate for Stargardt Disease Gene Therapy

07.09.2026

Tarsus Acquires iRenix Medical and Investigational Ocular Antiseptic IRX-101

07.08.2026

Cascade Prodrug Expands Collaboration with Netherlands-Based Uneedle to Advance Hypoxia-Targeted Wet AMD Therapy

Balance Ophthalmics Names Norbert Lowe Chief Commercial Officer Ahead of FSYX Launch image

07.08.2026

Balance Ophthalmics Names Norbert Lowe Chief Commercial Officer Ahead of FSYX Launch

07.08.2026

MeiraGTx Secures Financing Package of Up to $400 Million to Advance Gene Therapies

OKYO Pharma Receives FDA Feedback Supporting Phase 3 Path for Neuropathic Corneal Pain Treatment image

07.08.2026

UK-based OKYO Pharma Receives FDA Feedback Supporting Phase 3 Path for Neuropathic Corneal Pain Treatment

View More

EyewireTV

Eyewire TV July 8, 2026 thumbnail

07.08.2026

The Latest EyewireTV

Day In the Life of an Ophthalmology Resident

Advice from PGY4 Resident

Operating a Resident Clinic

Watch Episode

Watch the Latest Episode

Stay Updated

Sign up for Eyewire News and EyewireTV e‑newsletters to stay up to date on news in eye care!

Subscribe